Form 4: Aurinia Pharmaceuticals Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Director Brinda Balakrishnan sold 520 shares of Aurinia Pharmaceuticals to cover tax withholding obligations related to vesting of Restricted Stock Units.
Summary
- On May 21, 2024, Brinda Balakrishnan, a director of Aurinia Pharmaceuticals Inc., sold 520 shares of common stock.
- The sale was executed at a price of $5.74 per share.
- The transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units granted on May 19, 2023.
- Following the transaction, Balakrishnan directly owns 17,523 shares of Aurinia Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a routine stock sale for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Sales of shares by company insiders are a common occurrence, often related to compensation or portfolio diversification. It's important to consider the context of the sale, such as the reason for the sale and the amount of shares sold relative to the insider's total holdings.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 05/19/2023 | Date of grant for Restricted Stock Units |
| 05/21/2024 | Date of transaction (sale of shares) |
| 05/22/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.